ABBV - AbbVie Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue28,216,00025,638,00022,859,00019,960,000
Cost of Revenue6,686,0005,794,0004,239,0004,389,000
Gross Profit21,530,00019,844,00018,620,00015,571,000
Operating Expenses
Research Development4,982,0004,366,0004,101,0003,297,000
Selling General and Administrative5,905,0005,855,0005,663,0006,024,000
Non Recurring----
Others---750,000
Total Operating Expenses17,573,00016,015,00014,003,00014,460,000
Operating Income or Loss10,643,0009,623,0008,856,0005,500,000
Income from Continuing Operations
Total Other Income/Expenses Net-2,916,000-1,739,000-2,211,000-3,131,000
Earnings Before Interest and Taxes10,643,0009,623,0008,856,0005,500,000
Interest Expense-1,150,000-1,047,000-719,000-429,000
Income Before Tax7,727,0007,884,0006,645,0002,369,000
Income Tax Expense2,418,0001,931,0001,501,000595,000
Minority Interest----
Net Income From Continuing Ops5,309,0005,953,0005,144,0001,774,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income5,309,0005,953,0005,144,0001,774,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares5,283,0005,923,0005,118,0001,765,000